The Grants and Scientific Research Department was created as part of the Research and Development Center of AHP in 2012 in response to dynamic development of the modern medicine. Numerous scientists employed in the CCRD deal, among others, with development and implementation of new preventive, diagnostic, therapeutic and rehabilitation methods.
Język:
Research grants
The main goal of the Grants and Scientific Research Department is:
strengthening the links between science and the economy
implementing mechanisms increasing the use of the results of research and development works in industrial practice
increasing the share of young scientists benefiting the scientific funding
being part of a changing realit enabling scientists to develop and being part of a changing reality
The funds for launching the Research and Development Center were obtained from the Operational Program Innovative Economy 2007-2013 co-financed by the European Regional Development Fund. The grants implemented are co-financed from various sources, including under strategic programs (STRATEGMED) implemented by the National Center for Research and Development and from EU funds under the Intelligent Development Operational Program, as well as under the Regional Operational Program of the Śląskie Voivodeship. In addition, scientists of the Research and Development Center obtained funds to finance research under competitions announced by the National Science Center (OPUS, SONATA).
Funds for the facility and development of the current research activities conducted by the Centre for Cardiovascular Research and Development American Heart of Poland were obtained from the Operational Programme Innovative Economy 2007-2013, co-financed under the European Regional Development Fund.
The main objective of the CCRD research is to increase the competitiveness of science by creating organizational structures and procedures that will allow us for:
enhancing the quality of study
strengthening links between the science and the economy sector
increase the participation of young scientists in the use of funds for science
implementation of mechanisms to increase the level of application of research and development results in the industry practice
One source of funding for research grants are from the National Center for Research and Development. With these funds are financed research projects (grants), including:
projects STRATEGMED in which AHP acts as LEADER or as a PARTNER
project of Applied Research Programme, in which AHP is a PARTNER
The Center carries out research both individually and in large consortia, as a member and also as a project leader. Below is a list of the grants implemented:
Micro-injection vascular stent development technology (MICROINJSTENT)
New generation micro-injection vascular stent development technology
The aim of the project is to develop a technology for the production of a new generation of biodegradable vascular stents using the micro-injection method and to optimize the process of their implantation.
Project co-financed under Measure 4.1 of the Intelligent Development Operational Program 2014-2020 co-financed by the European Regional Development Fund
Implemented as part of the consortium:
Center of Polymer and Carbon Materials of the Polish Academy of Sciences (Leader)
American Heart of Poland SA
Agreement number: POIR.04.01.02-00-0105/17-00
Implementation period:
2020-04-01 - 2022-06-30
Project value:
PLN 1,365,659.10.
Co-financing:
PLN 1,270,062.96.
AHP subsidy:
PLN 910,860.60.
The influence of chondrocytes on biological response and healing of sternum after sternotomy
The impact of local delivery of allogeneic chondrocytes on the biological response and healing of bone structures of the sternum after sternotomy
The aim of the project is to observe and evaluate the biology of sternum chondrocytes, of porcine origin, cultured in vitro to regenerate a damaged sternum after median sternotomy.
The project received funding under the OPUS 13 competition carried out by the National Science Center
Agreement number: UMO – 2017/25/B/NZ5/02582
Implementation period:
04.04.2018-04.04.2021
Project value:
PLN 999,460.00.
Co-financing:
PLN 999,460.00.
Pericardial therapy of cardiomyopathy with stem cells
Innovative pericardial therapy of ischemic cardiomyopathy using stem cells and cytokines released from biodegradable microspheres
The aim of the project is to evaluate the pharmacokinetics of the endogenous and exogenous cytokine SDF-1 alpha and to study the tissue effects, including the reduction of the infarct area of the heart after the administration of biodegradable SDF-1 releasing microspheres into the pericardial sac with the simultaneous intravenous administration of stem cells.
The project received funding under the OPUS 12 competition carried out by the National Science Center
Agreement number: UMO – 2016/23/B/NZ5/02517
Implementation period:
01.10.2017-30.09.2021
Project value:
PLN 1,335,840.00.
Co-financing:
PLN 1,335,840.00.
The use of telemedicine in cardiac rehabilitation (RESTORE)
The use of modern telemedicine technologies in an innovative program of optimal cardiac rehabilitation in patients after myocardial revascularization
The project aims to improve the long-term prognosis of the patient population with coronary heart disease by creating, implementing and evaluating an optimal model of cardiac telerehabilitation in conjunction with adequate treatment of coronary heart disease.
The project received funding under the OPUS 12 competition carried out by the National Science Center
Project implemented under the ‘Prevention and treatment of civilization diseases’ STRATEGMED program by the consortium:
American Heart of Poland SA - Project Leader
Jerzy Kukuczka University School of Physical Education in Katowice.
DrEryk SA.
AGH University of Science and Technology
mTree Medical Solutions Sp. z o.o.
Fraunhofer Center for International Management and Knowledge Economy IMW
Agreement number: STRATEGMEDII/269043/20/NCBR/2017
Implementation period:
01.03.2016-30.06.2021
Project value:
PLN 15,996,230.00
Co-financing:
PLN 13,509,982.00.
AHP subsidy:
PLN 3,828,655.00.
Remote cardiac care as a support for dependent people
Remote cardiac care as a support for dependent people
The main aim of the Project is to increase the availability of health services for residents at risk of poverty or social exclusion living in the revitalization area or its vicinity in the City of Bytom. As part of the project, patients are covered by the ECG telemonitoring service for 12 months.
Project co-financed by the European Social Fund under the Regional Operational Program of the Silesian Voivodeship for 2014-2020, Priority Axis IX. Social inclusion, Measure 9.2 Accessible and effective social and health services, Sub-measure 9.2.1. Development of social and health services – ZIT.
Implemented in a consortium:
VIKI VIKI Michał Słodczyk sp. z o.o. - Project Leader
American Heart of Poland SA
Agreement number: UDA RPSL.09.02.01 24 02H9/19
Implementation period:
2020-04-01 - 2021-09-30
Project value:
PLN 1,365,659.10.
Co-financing:
PLN 1,270,062.96.
AHP subsidy:
PLN 910,860.60.
Biodegradable stent development (APOLLO)
Development and comprehensive evaluation of a biodegradable and flexible balloon-expanded endovascular stent based on thin bridges of high strength
The aim of the project is to develop a new, thin-bridge, biodegradable sirolimus eluting endovascular stent (PBES), as well as its comprehensive evaluation under preclinical conditions.
Project implemented under the ‘Prevention and treatment of civilization diseases’ STRATEGMED program by the consortium:
American Heart of Poland SA - Project Leader
Balton Sp. z o. o
Silesian Center for Heart Diseases in Zabrze
Center of Polymer and Carbon Materials of the Polish Academy of Sciences
Silesian University of Technology
Military University of Technology
Innovations for Heart and Vessels Sp. z o. o
Professor Zbigniew Religa Foundation for the Development of Cardiac Surgery
Agreement number: STRATEGMED2/269760/1/NCBR/2015
Implementation period:
01.09.2015 -28.02.2021
Project value:
PLN 13,914,129.36
Co-financing:
PLN 11,428,705.00
AHP subsidy:
PLN 1,384,640.00.
First Polish percutaneously implanted low-profile valve (INFLOW)
Development and implementation of the first Polish percutaneously implanted low-profile valve
The main aim of the project is to create a new generation of low-profile, balloon-expanded self-positioning aortic ‘InFlow’ valves using new composite materials and bio-based materials.
Project implemented under the ‘Prevention and treatment of civilization diseases’ STRATEGMED program by the consortium:
American Heart of Poland SA - Project Leader
Balton Sp. z o. o
Silesian Center for Heart Diseases in Zabrze
Center of Polymer and Carbon Materials of the Polish Academy of Sciences in Zabrze
Silesian University of Technology, Faculty of Mechanics and Technology
Experimental Station of the Institute of Animal Production, National Research Institute Grodziec Śląski Sp. z o.o.
Innovations for Heart and Vessels Sp. z o.o.
Heart Team Sp. z o. o
Agreement number: STRATEGMED1/233166/6/NCBR/2014
Implementation period:
01.11.2014-31.07.2018
Project value:
PLN 14,139,314.45
Co-financing:
PLN 11,187,654.87
AHP subsidy:
PLN 1,473,210.11.
Development of a method for the preparation of drug eluting stents (BSM STENT)
Development of a method of obtaining self-expanding, biodegradable, polymer drug-releasing vascular stents.
The aim of the project is to create a working prototype of a bioresorbable, self-expanding under the influence of temperature, endovascular stent releasing a drug preventing restenosis, using an innovative micro-injection technique, and to test its usefulness and therapeutic behavior in preclinical studies.
Project implemented as part of the consortium’s Applied Research Program:
Center of Polymer and Carbon Materials of the Polish Academy of Sciences in Zabrze
American Heart of Poland S.A.
Innovations for Heart and Vessels Sp. z o.o.
Agreement number: PBS3/A9/38/2015
Implementation period:
01.04.2015-30.09.2018
Project value:
PLN 4,750,484.00.
Co-financing:
PLN 3,941,095.00
AHP subsidy:
PLN 1,452,515.50.
The use of medical data teletransmission to improve the quality of life (MONITEL)
The use of medical data teletransmission to improve the quality of life of patients with heart failure and reduce the costs of their treatment
The project is aimed at creating devices for remote diagnostics of patients with cardiological diseases. To achieve this goal, it is obligatory to develop a reliable monitoring system that allows remote continuous evaluation of various parameters for predicting of cardiovascular events with the possibility of prior intervention.
Project implemented under the ‘Prevention and treatment of civilization diseases’ STRATEGMED program by the consortium:
Silesian Center for Heart Diseases - Project Leader
American Heart of Poland SA
Centralny Ośrodek Informatyki Górnictwa SA
Ente sp. z o.o.
Polish-Japanese Academy of Information Technology
Kardio - Med. Silesia Sp. z o.o.
Institute of Medical Technology and Apparatus ITAM
Novum SA
Agreement number: 1/233221/3/NCBR/2014
Implementation period:
01.09.2014-31.12.2016
Project value:
PLN 19,300,000.00.
Co-financing:
PLN 15,425,000.00.
AHP subsidy:
PLN 715,227.75.
Influence of intramural injection of cholesterol to develop an atherosclerosis model
Influence of intramural injection of cholesterol under conditions of hyperglycemia and high cholesterol diet on the vascular response for the development of an atherosclerosis model in the domestic pig
The project aims to investigate the possibility of heart regeneration using autologous mesinchemical stromal cells (MSCs), administered to patients with advanced heart failure directly into the heart muscle or through a cell-enriched scaffold (scaffold). The project is dedicated to patients with severe, symptomatic, ischemic heart failure who have exhausted the possibilities of modern pharmacotherapy and no-option patients. The scaffold (CERES) enriched with MSC cells (CERES-MSC) developed, tested and proven by the PHOENIX project will eventually become a finished product that should stimulate the revascularization of the ischemic area of the heart muscle, restoring its contractility. The aim of the project is therefore to develop and ensure access to a modern, cost-effective treatment method for a wider patient population that will increase survival time and quality of life.
The project received funding under the SONATA 6 competition carried out by the National Science Center
Agreement number: UMO-2013/11/D/NZ5/03820
Implementation period:
11.2014-12.2015
Project value:
PLN 316,100.00.
Co-financing:
PLN 316,100.00.
Establishment of the Research and Development Center
Establishment of the Research and Development Center at American Heart of Poland Sp. z o.o.
The project consisted of:
execution of construction works,
purchase of devices,
intangible assets,
As a result of the project, a clinical part and experimental facilities of the R&D Center were created.
Project co-financed under the Operational Program Innovative Economy 2007-2013, Priority Axis IV. Investments in innovative undertakings, Measure 4.5. Support for investments of great importance for the economy, Sub-measure 4.5.2. Support for investments in the modern services sector.
Agreement number: UDA-POIG.04.05.02-00-100/09-00
Implementation period:
07.2010 - 12.2011
Project value:
PLN 36,313,750.00
Co-financing:
PLN 18,156,875.00